ELOX
Financials
- Market Capitalization 7.99 M
- Employee 7
- Founded 1999
- CEO N/A
- Website www.eloxxpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BGGWS3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4866 |  BRTX BioRestorative Therapies, Inc. - Common Stock | 0.35 USD | -5.41% | -12.50% | -2.78% | -79.77% | 8.92 M USD | ||
| 4879 |  IMNN Imunon, Inc. - Common Stock | 2.03 USD | +4.10% | +14.69% | -0.98% | -37.54% | 8.53 M USD | ||
| 4888 |  MTVA MetaVia Inc. - Common Stock | 1.55 USD | -1.90% | +6.90% | -14.84% | +138.46% | 8.00 M USD | ||
| 4898 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.00 USD | -5.21% | +14.94% | +55.64% | -15.86% | 7.60 M USD |
Frequently asked questions about Eloxx Pharmaceuticals, Inc.
What is the Eloxx Pharmaceuticals, Inc. stock price today?
The current price of Eloxx Pharmaceuticals, Inc. (ELOX) is 11.6. Over the past 24 hours, the stock has changed by +5.94%. Follow the ELOX chart for real-time price dynamics.
What is the stock ticker of Eloxx Pharmaceuticals, Inc.?
Eloxx Pharmaceuticals, Inc. trades under the ticker ELOX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Eloxx Pharmaceuticals, Inc. stock going up?
ELOX has changed by -5.77% over the last week, +16.00% over the last month, and +16.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Eloxx Pharmaceuticals, Inc. net income for the last quarter?
Eloxx Pharmaceuticals, Inc. reported net income of -3.75 M for the last quarter. The previous quarter showed 1.29 B, which means net income changed by -100.29%.
How many employees does Eloxx Pharmaceuticals, Inc. have?
As of the latest available data, Eloxx Pharmaceuticals, Inc. has 7 employees. Workforce size can provide additional context about the company's scale and operations.
What is Eloxx Pharmaceuticals, Inc. EBITDA?
Eloxx Pharmaceuticals, Inc. EBITDA is -3.73 M, and its EBITDA margin is -6 664.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Eloxx Pharmaceuticals, Inc. stock?
You can buy Eloxx Pharmaceuticals, Inc. (ELOX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Eloxx Pharmaceuticals, Inc. stock?
Investing in Eloxx Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELOX chart and related analysis on metatrader.com as part of your research.